StockSelector.com
  Research, Select, & Monitor Friday, November 16, 2018 1:00:40 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cara Therapeutics Inc.$18.76$.653.59%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cara Therapeutics Inc. has an overall rank of 6955 out of 7255 stocks based on 6 positive rankings and 12 negative rankings.

Positive Rankings
Estimated Revenue Growth
Cara Therapeutics Inc. rank is 14
Positive Stoch Cross
Cara Therapeutics Inc. rank is 91
Target Prices
The average analysts' target price is $30.00 for Cara Therapeutics Inc. using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cara Therapeutics Inc. is ranked 194.
Debt-to-Equity
Cara Therapeutics Inc. rank is 221
Highest Cash Growth
Cara Therapeutics Inc. rank is 341
Low Put/Call
Cara Therapeutics Inc. has a low Put/Call ratio of 0.37 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cara Therapeutics Inc. is ranked 1027.
Negative Rankings
Price-to-Sales
Cara Therapeutics Inc. rank is 106
Missed Whisper
According to EarningsWhispers.com, Cara Therapeutics Inc. missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Negative Net Margin
Cara Therapeutics Inc. rank is 200
Negative ROA
Cara Therapeutics Inc. rank is 457
Down EPS Surprise
Cara Therapeutics Inc. missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROE
Cara Therapeutics Inc. rank is 492
Price-to-Book
Cara Therapeutics Inc. rank is 639
Negative Revenue Growth
Cara Therapeutics Inc. rank is 673
10 Day Loss
Cara Therapeutics Inc. rank is 1278
High vPut/Call
Cara Therapeutics Inc. has a high Put/Call ratio of 0.91 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cara Therapeutics Inc. is ranked 1468.
90 Day Loss
Cara Therapeutics Inc. rank is 1815







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.